ConductScience.org, home

Paper24809776

A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion.

Bendifallah S and 10 others. Br J Cancer, 2014. Cited by 71 papers, by iCite.

Cite this record

ConductScience Library. A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion. Papers, record 24809776. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24809776

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A clue towards improving the European Society of Medical Oncology risk group classification in apparent early stage endometrial cancer? Impact of lymphovascular space invasion.
PubMed
Journal
Br J Cancer
PubMed
Year
2014
PubMed
Publication types
Journal Article, Multicenter Study
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
2.52
iCite
Revised in PubMed
2021-10-21
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bendifallah SS
2Canlorbe GG
3Raimond EE
4Hudry DD
5Coutant CC
6Graesslin OO
7Touboul CC
8Huguet FF
9Cortez AA
10Daraï EE
11Ballester MM

Source PubMed

Download CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Endometrial NeoplasmsMajor topic
Lymphatic VesselsMajor topic
Neoplasm Recurrence, LocalMajor topic
Adult
Aged
Aged, 80 and over
Combined Modality Therapy
Disease-Free Survival
Female
Humans
Kaplan-Meier Estimate
Lymphatic Metastasis
Middle Aged
Multivariate Analysis
Neoplasm Invasiveness
Neoplasm Staging
Prognosis
Prospective Studies
Quality Improvement
ROC Curve
Risk
Risk Assessment

Source PubMed

Download CSV of topics

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123770577Histological and immunohistochemical profiles predict lymph node status in women with low-intermediate risk endometrial cancer.Gynecol Oncol2013https://conductscience.org/library/papers/23770577PubMed
27539772The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining.Gynecol Oncol1995https://conductscience.org/library/papers/7539772PubMed
314984936A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study.Gynecol Oncol2004https://conductscience.org/library/papers/14984936PubMed
419522800Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality.BJOG2009https://conductscience.org/library/papers/19522800PubMed
523954391Association between tumor diameter and lymphovascular space invasion among women with early-stage endometrial cancer.Int J Gynaecol Obstet2013https://conductscience.org/library/papers/23954391PubMed
61989916Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.Gynecol Oncol1991https://conductscience.org/library/papers/1989916PubMed
719033573Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.J Natl Cancer Inst2008https://conductscience.org/library/papers/19033573PubMed
821697683Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique.Int J Gynecol Cancer2011https://conductscience.org/library/papers/21697683PubMed
919367689Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium.Int J Gynaecol Obstet2009https://conductscience.org/library/papers/19367689PubMed
1022155415Do uterine risk factors or lymph node metastasis more significantly affect recurrence in patients with endometrioid adenocarcinoma?Gynecol Oncol2012https://conductscience.org/library/papers/22155415PubMed
1117161155Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.Int J Gynaecol Obstet2006https://conductscience.org/library/papers/17161155PubMed
1222576066Comparison of diagnostic accuracy of frozen section with imprint cytology for intraoperative examination of sentinel lymph node in early-stage endometrial cancer: results of Senti-Endo study.Ann Surg Oncol2012https://conductscience.org/library/papers/22576066PubMed
136822361Two pathogenetic types of endometrial carcinoma.Gynecol Oncol1983https://conductscience.org/library/papers/6822361PubMed
1419070889Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.Lancet2009https://conductscience.org/library/papers/19070889PubMed
1520206777Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.Lancet2010https://conductscience.org/library/papers/20206777PubMed
1616330675Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study.J Clin Oncol2006https://conductscience.org/library/papers/16330675PubMed
173652025Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study.Cancer1987https://conductscience.org/library/papers/3652025PubMed
1823221731Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.Int J Gynecol Cancer2013https://conductscience.org/library/papers/23221731PubMed
1924550988Endometrial cancer: molecular and cellular basis of tumor development, novel biomarkers and therapeutic agents, and innovative research approaches.Obstet Gynecol Int2014https://conductscience.org/library/papers/24550988PubMed
2012468325Surgical stage I endometrial cancer: predictors of distant failure and death.Gynecol Oncol2002https://conductscience.org/library/papers/12468325PubMed

See all 28 referencesDownload CSV of references

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
42973791A nomogram integrating YTHDC2 expression and clinicopathological parameters for predicting endometrial cancer recurrence: a multicenter retrospective study.Front Oncol2026https://conductscience.org/library/papers/42973791PubMed
42482756A novel nomogram incorporating preoperative systemic inflammatory response index and clinicopathological parameters for predicting lymph node metastasis in endometrial cancer.Front Oncol2026https://conductscience.org/library/papers/42482756PubMed
40973043Bridging adjuvant treatment gaps: low and intermediate risk endometrial carcinoma patients care in Salah Azaiez Institute in Tunisia.Oncologist2025https://conductscience.org/library/papers/40973043PubMed
40304351Analysis of the Correlation between MRI Imaging Signs and Lymphovascular Space Invasion in Endometrial CancerCurr Med Imaging2025https://conductscience.org/library/papers/40304351PubMed
39610926Guiding adjuvant radiotherapy in stage III endometrial cancer: a prognostic model based on SEER.Front Oncol2024https://conductscience.org/library/papers/39610926PubMed
38916618Both intra- and peri-tumoral radiomics signatures can be used to predict lymphatic vascular space invasion and lymphatic metastasis positive status from endometrial cancer MR imaging.Abdom Radiol (NY)2024https://conductscience.org/library/papers/38916618PubMed
38775501Preoperative cancer antigen-125 levels as a predictor of recurrence in early-stage endometrial cancer.Rev Assoc Med Bras (1992)2024https://conductscience.org/library/papers/38775501PubMed
37963944Effects of radiotherapy on the survival of patients with stage IA and low-grade stage IB uterine endometrioid carcinoma.Sci Rep2023https://conductscience.org/library/papers/37963944PubMed
37153054Evaluation of sterol‑o‑acyl transferase 1 and cholesterol ester levels in plasma, peritoneal fluid and tumor tissue of patients with endometrial cancer: A pilot study.Oncol Lett2023https://conductscience.org/library/papers/37153054PubMed
36915143The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer.Eur J Med Res2023https://conductscience.org/library/papers/36915143PubMed
36662766Bioinformatics reveal elevated levels of Myosin Vb in uterine corpus endometrial carcinoma patients which correlates to increased cell metabolism and poor prognosis.PLoS One2023https://conductscience.org/library/papers/36662766PubMed
36523313The association of tumor diameter with lymph node metastasis and recurrence in patients with endometrial cancer: a systematic review and meta-analysis.Transl Cancer Res2022https://conductscience.org/library/papers/36523313PubMed
35453837Quantitative Measurement of Progesterone Receptor Immunohistochemical Expression to Predict Lymph Node Metastasis in Endometrial Cancer.Diagnostics (Basel)2022https://conductscience.org/library/papers/35453837PubMed
35225474Predicting Factors for Pelvic Lymph Node Metastasis in Patients with Apparently Early-Stage Endometrial Cancer.Asian Pac J Cancer Prev2022https://conductscience.org/library/papers/35225474PubMed
35114747The Evaluation of Preoperative 18F-FDG PET/CT in Patients with Endometrial Cancer and the Correlation Between PET Parameters and Postoperative Pathology Results.Mol Imaging Radionucl Ther2022https://conductscience.org/library/papers/35114747PubMed
34553020Development of a seven-gene tumor immune microenvironment prognostic signature for high-risk grade III endometrial cancer.Mol Ther Oncolytics2021https://conductscience.org/library/papers/34553020PubMed
34485158A 4-Gene Signature Associated With Recurrence in Low- and Intermediate-Risk Endometrial Cancer.Front Oncol2021https://conductscience.org/library/papers/34485158PubMed
34220310Prediction of lymphovascular space invasion in patients with endometrial cancer.Int J Med Sci2021https://conductscience.org/library/papers/34220310PubMed
34137929Volumetric ADC histogram analysis for preoperative evaluation of LVSI status in stage I endometrioid adenocarcinoma.Eur Radiol2022https://conductscience.org/library/papers/34137929PubMed
33856667The Prediction of Recurrence in Low-Risk Endometrial Cancer: Is It Time for a Paradigm Shift in Adjuvant Therapy?Reprod Sci2022https://conductscience.org/library/papers/33856667PubMed

See all 38 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/24809776

GET https://conductscience.org/api/papers/v1/24809776/references?page=2